Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN114478375A reveals a novel Pd-catalyzed route for quinolin-2(1H)one derivatives, offering cost-effective API intermediate manufacturing with high yields.
Patent CN113735778B enables efficient silver oxide promoted synthesis. Delivers high purity imidazole compounds with substantial cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Novel patent CN115703691B details safer synthesis for isotope standards. Reduces toxicity and cost for pharma intermediate supply chains.
Patent CN103274917B reveals copper-catalyzed route. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing for global buyers.
Patent CN106866389A reveals copper-catalyzed asymmetric synthesis. Offers high enantioselectivity up to 95% ee for pharmaceutical intermediates.
Patent CN107011218A details copper catalyzed asymmetric amination enabling efficient synthesis of chiral amines with improved supply chain reliability and cost effectiveness for global buyers
Patent CN117362140B reveals high-yield photocatalytic route. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel cobalt-catalyzed carbonylation method offers cost-effective scalable production for pharmaceutical intermediates with high purity and operational simplicity for global supply chains.
Novel iridium-catalyzed asymmetric method offers high selectivity and mild conditions for pharmaceutical intermediate manufacturing supply chain optimization and cost efficiency.
Patent CN105859620B reveals novel phenanthridine synthesis enabling cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN116813544B reveals catalyst-free heating method for quinoline. Reduces cost and improves supply chain reliability for pharmaceutical intermediates globally.
Patent CN108503574A enables efficient Pd-Cu co-catalyzed synthesis. Delivers high-purity pharmaceutical intermediates with reduced cost and scalable supply chain reliability.
Efficient base-catalyzed route for 2H-pyran-2-one derivatives using sulfur ylides. Offers cost reduction and scalability for pharmaceutical intermediates manufacturing.
Patent CN113735756A details a high-yield Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering cost-effective pharma intermediate manufacturing.
Novel Rh-catalyzed one-pot synthesis of indolo[2,1-a]isoquinolines using sulfur ylides. Efficient route for pharmaceutical intermediates with mild conditions.
Patent CN103539730A reveals scalable routes for Dabigatran intermediates using metal reduction or amine-promoted hydrogenation, ensuring supply continuity.
Patent CN115246786B reveals Pd-catalyzed carbonylation for high-purity intermediates. Cost-effective and scalable manufacturing solutions for global pharmaceutical supply chains.
Novel palladium-catalyzed carbonylation route enables high-purity polycyclic quinolinone production with simplified processing and substantial supply chain cost optimization for global buyers.
Patent CN114195818B enables metal-free synthesis of high-purity 4-arylthiocoumarin intermediates, offering substantial cost reduction and scalable supply chain reliability for global pharmaceutical manufacturers.
Patent CN113307778A reveals a novel Mo/Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering mild conditions and high efficiency for API manufacturing.